SMMT logo
NASDAQ · SMMTBiotechnologyUpdated Nov 2, 2026

Summit Therapeutics Inc. current ratio

Liquidity, historical trends, and peer comparisons.

The Current Ratio as of November 2026 (TTM) for Summit Therapeutics Inc. (SMMT) is 6.96

According to Summit Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.96. This represents a change of -0.70% compared to the average of 7.01 of the last 4 quarters.

Summit Therapeutics Inc. (SMMT) Historical Current Ratio (quarterly & annually)

How has SMMT Current Ratio performed in the past?

The mean historical Current Ratio of Summit Therapeutics Inc. over the last ten years is 6.89. The current 6.96 Current Ratio has changed 0.96% with respect to the historical average. Over the past ten years (40 quarters), SMMT's Current Ratio was at its highest in in the June 2023 quarter at 19.07. The Current Ratio was at its lowest in in the January 2018 quarter at 1.56.

Quarterly (TTM)
Annual

Average

6.89

Median

5.34

Minimum

1.56

Maximum

16.93

Summit Therapeutics Inc. (SMMT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Summit Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 345.87%

Maximum Annual Current Ratio = 16.93

Minimum Annual Increase = -52.93%

Minimum Annual Current Ratio = 1.56

Quarterly (TTM)
Annual
YearCurrent RatioChange
20259.87-2.82%
202410.159.22%
20239.30-45.09%
202216.93345.87%
20213.80-13.84%
20204.41-29.74%
20196.2776.00%
20193.56128.58%
20181.56-49.03%
20173.06-52.93%

Summit Therapeutics Inc. (SMMT) Average Current Ratio

How has SMMT Current Ratio performed in the past?

The current Current Ratio of Summit Therapeutics Inc. (SMMT) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

9.77

5-year avg

10.01

10-year avg

6.89

Summit Therapeutics Inc. (SMMT) Current Ratio vs. Peers

How is SMMT’s Current Ratio compared to its peers?

Summit Therapeutics Inc.’s Current Ratio is greater than Spero Therapeutics, Inc. (6.12), greater than Acurx Pharmaceuticals, Inc. (3.88), greater than ImmunityBio, Inc. (5.72), less than Palisade Bio, Inc. (24.26), greater than Seres Therapeutics, Inc. (2.11), greater than Traws Pharma, Inc. (0.43), greater than Enanta Pharmaceuticals, Inc. (3.76),

Build a custom stock screener for Summit Therapeutics Inc. (SMMT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Summit Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Summit Therapeutics Inc. (SMMT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Summit Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Summit Therapeutics Inc.'s Current Ratio?

How is the Current Ratio calculated for Summit Therapeutics Inc. (SMMT)?

What is the highest Current Ratio for Summit Therapeutics Inc. (SMMT)?

What is the 3-year average Current Ratio for Summit Therapeutics Inc. (SMMT)?

What is the 5-year average Current Ratio for Summit Therapeutics Inc. (SMMT)?

How does the current Current Ratio for Summit Therapeutics Inc. (SMMT) compare to its historical average?